相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。A Pyroptosis-Related Gene Panel for Predicting the Prognosis and Immune Microenvironment of Cervical Cancer
Haoran Hu et al.
FRONTIERS IN ONCOLOGY (2022)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Molecular pathology of urothelial carcinoma
Antonio Lopez-Beltran et al.
HUMAN PATHOLOGY (2021)
OCT3/4 enhances tumor immune response by upregulating the TET1-dependent NRF2/MDM2 axis in bladder cancer
Minghuan Mao et al.
GENOMICS (2021)
CHMP4C regulates lung squamous carcinogenesis and progression through cell cycle pathway
Bo Liu et al.
JOURNAL OF THORACIC DISEASE (2021)
Identification of the Functions and Prognostic Values of RNA Binding Proteins in Bladder Cancer
Yue Wu et al.
FRONTIERS IN GENETICS (2021)
Prognostic value of CLIC3 mRNA overexpression in bladder cancer
Mei Chen et al.
PEERJ (2020)
Chromatin modified protein 4C (CHMP4C) facilitates the malignant development of cervical cancer cells
Shu-Li Lin et al.
FEBS OPEN BIO (2020)
Bladder Cancer: A Review
Andrew T. Lenis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Treatment of epithelial ovarian cancer
Lindsay Kuroki et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Combined genetic and epigenetic alterations of the TERT promoter affect clinical and biological behavior of bladder cancer
Ricardo Leao et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Changes in ovarian cancer survival during the 20 years before the era of targeted therapy
Jung-Yun Lee et al.
BMC CANCER (2018)
Implications of TERT promoter mutations and telomerase activity in urothelial carcinogenesis
Cagatay Guenes et al.
NATURE REVIEWS UROLOGY (2018)
Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: clinical impacts in cancer
Ricardo Leao et al.
JOURNAL OF BIOMEDICAL SCIENCE (2018)
Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
Sebastien Antoni et al.
EUROPEAN UROLOGY (2017)
Bridging the gender gap
James McKiernan et al.
NATURE (2017)
Telomeres in cancer: tumour suppression and genome instability
John Maciejowski et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
MicroRNA-154 as a prognostic factor in bladder cancer inhibits cellular malignancy by targeting RSF1 and RUNX2
Xin Zhao et al.
ONCOLOGY REPORTS (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Understanding TERT Promoter Mutations: A Common Path to Immortality
Robert J. A. Bell et al.
MOLECULAR CANCER RESEARCH (2016)
Replication Timing of Human Telomeres is Conserved during Immortalization and Influenced by Respective Subtelomeres
Laure Piqueret-Stephan et al.
SCIENTIFIC REPORTS (2016)
High Coexpression of Runt-related Transcription Factor 2 (RUNX2) and p53 Independently Predicts Early Tumor Recurrence in Bladder Urothelial Carcinoma Patients
Eman Abdelzaher et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2016)
Intratumour Heterogeneity in Urologic Cancers: From Molecular Evidence to Clinical Implications
Marco Gerlinger et al.
EUROPEAN UROLOGY (2015)
Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature
Luis A. Kluth et al.
EUROPEAN UROLOGY (2015)
The Long and Short of Telomere Length and Diabetes
Cathy E. Elks et al.
DIABETES (2014)
A census of human RNA-binding proteins
Stefanie Gerstberger et al.
NATURE REVIEWS GENETICS (2014)
Association Between Smoking and Risk of Bladder Cancer Among Men and Women
Neal D. Freedman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
The effect of age and gender on bladder cancer: a critical review of the literature
Shahrokh F. Shariat et al.
BJU INTERNATIONAL (2010)
Oct-3/4 expression reflects tumor progression and regulates motility of bladder cancer cells
Chao-Ching Chang et al.
CANCER RESEARCH (2008)
OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer
Yaser Atlasi et al.
INTERNATIONAL JOURNAL OF CANCER (2007)